Free CME EducationOnline CME Courses Free

Love is in the Air - Don't let Aspirin-Exacerbated Respiratory Disease (AERD) Take Your Breath Away (CE Nurse)

Course Format: Online Video
Course Credit: 1.00
Rewards Points Earned: 25
Course Category: *AAN Network Courses, *Asthma, *Asthma & Allergy, Allergy/Immunology, Internal Medicine
Faculty: Tania Laidlaw
Course Producer: Allergy Asthma Network
Course Cost: $17.99
Mobile Friendly: Yes
Course Release Date: April 06, 2018
Course Expiration Date: December 31, 2022
Program Summary: AERD, Aspirin-exacerbated Respiratory Disease, is a high impact health issue for those that suffer with the concern. Dr. Tania Laidlaw reviews the pathophysiology of AERD and discusses treatment and management.

Objectives

  1. Participant will be able to identify the 3 main issues in identification of AERD
  2. Participant will be to discuss the AERD patients possible reactions to NSAIDs
  3. Participant will be able to identify diagnostic criteria for AERD

Tania Laidlaw, MD

Dr. Tanya M. Laidlaw completed her medical degree at the University of Massachusetts Medical School, her residency in pediatrics at Massachusetts General Hospital, and then entered an Allergy/Immunology fellowship at the Brigham and Women’s Hospital in Boston, Massachusetts.

She performed her research training in the laboratory of Joshua A. Boyce, MD, where she focused on the pathogenesis of asthma and Aspirin Exacerbated Respiratory Disease (AERD), and the pro-inflammatory role of platelets and Prostaglandin D2 in this disorder. She joined the faculty in 2009, and is now an Assistant Professor of Medicine at Harvard Medical School, and is the Director of Translational Research in Allergy at the Brigham and Women’s Hospital. Her research continues to be focused on understanding AERD, and she is dedicated to investigating the causative mechanisms of Chronic Rhinosinusitis with Nasal Polyposis and of AERD, and exploring new treatments for these diseases. Her group at the Brigham and Women’s Hospital’s AERD Center follows over 700 patients with nasal polyps and AERD and has several ongoing research studies that are recruiting and enrolling patients. Dr. Laidlaw has been the Principal Investigator for NIH-funded translational studies, as well as many industry-sponsored Phase II and Phase III clinical trials for new medications and biologic therapies aimed at treating Chronic Rhinosinusitis with Nasal Polyposis.

You need to log in or create a user account before you can enroll.